Board Change • Jun 24
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • May 07
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 09
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Mar 10
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Dec 31
New major risk - Revenue and earnings growth Revenue has declined by 0.1% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Revenue has declined by 0.1% over the past year. Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Board Change • Nov 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Price Target Changed • Sep 19
Price target increased by 55% to дин43,714 Up from дин28,141, the current price target is provided by 1 analyst. New target price is 21% above last closing price of дин36,000. Stock is up 16% over the past year. The company posted earnings per share of дин4,786 last year. Board Change • Sep 19
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Aug 19
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Price Target Changed • Aug 19
Price target increased by 55% to дин43,714 Up from дин28,141, the current price target is provided by 1 analyst. New target price is 25% above last closing price of дин35,101. Stock is up 38% over the past year. The company posted earnings per share of дин4,786 last year. New Risk • May 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Announcement • May 14
Messer Tehnogas AD, Annual General Meeting, Jun 17, 2025 Messer Tehnogas AD, Annual General Meeting, Jun 17, 2025. Reported Earnings • May 03
Full year 2024 earnings released Full year 2024 results: Revenue: дин21.9b (up 2.2% from FY 2023). Net income: дин4.97b (up 38% from FY 2023). Profit margin: 23% (up from 17% in FY 2023). The increase in margin was primarily driven by lower expenses. New Risk • Apr 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Board Change • Mar 28
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jan 13
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. President of the Board Virginia Esly was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Dec 11
Messer Tehnogas AD Announces CEO Changes Messer Tehnogas AD announced it has appointed Valentin Ilievski as new CEO. Ilievski will replace Ernst Bode who has resigned, effective December 31, Messer Tehnogas said in a filing with the Belgrade bourse on Monday. Valentin Ilievski previously served as president of Messer Tehnogas board. He also serves as Messer's senior vice president for Southeastern Europe and CEO of Messer Slovenija. Messer Tehnogas also said it has appointed Virginia Gabriele Esly to succeed Ilievski as new board president. Esly currently holds the position of chief operating officer for Europe at Messer. Announcement • Sep 28
Messer SE & Co. KGaA to Launch Buyout Bid for Serbian Unit on September 30 German industrial gases manufacturer Messer SE & Co. KGaA said on September 27, 2024 it will launch on September 30 a second buyout bid for the remaining 14.40% of its Serbian subsidiary Messer Tehnogas AD it does not already own. Messer is offering to pay RSD 31,250 ($299/EUR 267) per each of the 149,325 Messer Tehnogas shares it targets, valuing the stake at nearly EUR 40 million, it said in a filing with the Belgrade bourse. The bid will remain open until October 28, according to the filing. In April, Messer raised its shareholding in Messer Tehnogas to 85.60% from 82.09% following a buyout bid priced at RSD 2,500 per share. Valuation Update With 7 Day Price Move • Aug 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to дин30,019, the stock trades at a trailing P/E ratio of 8.7x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total returns to shareholders of 82% over the past three years. Reported Earnings • May 09
Full year 2023 earnings released Full year 2023 results: Revenue: дин21.8b (up 32% from FY 2022). Net income: дин3.60b (up 56% from FY 2022). Profit margin: 17% (up from 14% in FY 2022). The increase in margin was driven by higher revenue. New Risk • Apr 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Announcement • Mar 28
Messer SE & Co. KGaA launched a bid to acquire remaining 17.91% stake in Messer Tehnogas AD (BELEX:TGAS) for RSD 4.6 billion. Messer SE & Co. KGaA launched a bid to acquire remaining 17.91% stake in Messer Tehnogas AD (BELEX:TGAS) for RSD 4.6 billion on March 25, 2024. Offer price per share is RSD 25,000. The bid is open until April 15, 2024. As part of acquisition, 185,711 shares will be acquired. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to дин22,027, the stock trades at a trailing P/E ratio of 8.4x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 63% over the past three years. New Risk • Sep 26
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risk Large one-off items impacting financial results. Board Change • Aug 08
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Is New 90 Day High Low • Mar 15
New 90-day high: дин14,487 The company is up 3.0% from a price of дин14,000 on 15 December 2020. Outperformed the Serbian market which is up 2.0% over the last 90 days. Lagged the Chemicals industry, which is up 7.0% over the same period. Is New 90 Day High Low • Oct 01
New 90-day high: дин13,182 The company is up 2.0% from its price of дин12,900 on 02 July 2020. The Serbian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. 